Medicalgorithmics Starts Providing ECG Cardiac Safety Services Using AI in a Clinical Trial for a New Drug
Medicalgorithmics has initiated its involvement in providing cardiac safety services for a pioneering clinical trial of a new medication. The trial, now in the drug dosing phase, utilizes Medicalgorithmics’ advanced AI software and ECG diagnostic devices. This initiative is a part of Project OATD-01, carried out for the Polish company Molecure and managed by Simbec-Orion. This exemplifies a significant expansion for Medicalgorithmics into the domain of cardiac safety in clinical trials.